Skip to main content
. Author manuscript; available in PMC: 2021 Aug 12.
Published in final edited form as: J Heart Lung Transplant. 2019 Jun 20;38(9):972–981. doi: 10.1016/j.healun.2019.06.006

Figure 2.

Figure 2.

Probability of freedom from Infection requiring hospitalization or intravenous antimicrobials (A), Re-hospitalization (B), PTLD (C) and New Onset Diabetes (D) in the first year post-transplant with corresponding 95% confidence interval. The number of participants at risk is presented at select time points along the x-axis. Censored data is shown as circles. One participant with diabetes pre-transplant is excluded from panel D.